Cushman & Wakefield (CWK)
(Delayed Data from NYSE)
$13.43 USD
-0.29 (-2.11%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $13.46 +0.03 (0.22%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Price, Consensus and EPS Surprise
CWK 13.43 -0.29(-2.11%)
Will CWK be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CWK based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CWK
Terreno (TRNO) Leases San Leandro Property, Sees Decent Demand
Terreno (TRNO) Announces Lease Renewal, Sees Decent Demand
CWK: What are Zacks experts saying now?
Zacks Private Portfolio Services
What's in Store for Simon Property (SPG) This Earnings Season?
Vornado (VNO) to Report Q2 Earnings: What's in the Cards?
3 REITs Likely to Emerge Victorious This Earnings Season
Other News for CWK
Cushman & Wakefield Releases In-Depth Report Providing Blueprint to Reimagine Cities
Cushman & Wakefield management to meet with Piper Sandler
Cranswick Insider Reinvests Dividend into Shares
Cranswick Insider Reinvests Dividend into Shares
Cushman & Wakefield management to meet with Piper Sandler